bPertussis is a highly contagious, acute respiratory illness caused by the bacterial pathogen Bordetella pertussis. Despite nearly universal vaccine coverage, pertussis rates in the United States have been rising steadily over the last 20 years. Our failure to comprehend and counteract this important public health concern is due in large part to gaps in our knowledge of the disease and the mechanisms of vaccine-mediated protection. Important questions about pertussis pathogenesis and mechanisms of vaccine effectiveness remain unanswered due to the lack of an animal model that replicates the full spectrum of human disease. Because current animal models do not meet these needs, we set out to develop a nonhuman primate model of pertussis. We inoculated rhesus macaques and olive baboons with wild-type B. pertussis strains and evaluated animals for clinical disease. We found that only 25% of rhesus macaques developed pertussis. In contrast, 100% of inoculated baboons developed clinical pertussis. A strong anamnestic response was observed when convalescent baboons were infected 6 months following recovery from a primary infection. Our results demonstrate that the baboon provides an excellent model of clinical pertussis that will allow researchers to investigate pertussis pathogenesis and disease progression, evaluate currently licensed vaccines, and develop improved vaccines and therapeutics.
Whooping cough is a highly contagious, acute respiratory illness caused by the bacterial pathogen Bordetella pertussis (for a review, see references 10 and 17). The introduction of pertussis vaccines in the 1940s and nationwide coverage in excess of 95% led to a dramatic decrease in the incidence of the disease. However, for unexplained reasons, pertussis rates in the United States have been rising steadily over the last 20 years for infants, children, and adolescents (1). With more than 21,000 reported cases in the United States in 2010, the highest number since the 1950s, pertussis is the most common of the vaccine-preventable diseases (2). This resurgence is mirrored throughout the industrial world, despite similar high rates of vaccination (12,20,31). Several hypotheses have been suggested for the increase in cases, but there is no consensus within the scientific community (9). Our failure to comprehend and counteract this important public health concern is due in large part to gaps in our knowledge of the disease and the mechanisms of vaccine-mediated protection. In order to fill these gaps, a good animal model of pertussis is required.In humans, infection with B. pertussis results in a wide spectrum of clinical manifestations that depends on the age and immune status of the host and ranges from mild respiratory symptoms to a severe cough illness which may be accompanied by the hallmark inspiratory whoop and posttussive emesis (4). Clinical signs include high leukocytosis, hypoglycemia, and reduced pulmonary capacity. Because of the acute nature of pertussis infections and because B. pertussis is a strict human pathogen with...